KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVS) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to 0.22%.

  • Novartis Ag's Return on Capital Employed rose 200.0% to 0.22% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.22%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.22% for FY2025, which is 200.0% up from last year.
  • Per Novartis Ag's latest filing, its Return on Capital Employed stood at 0.22% for Q4 2025, which was up 200.0% from 0.24% recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's Return on Capital Employed registered a high of 0.24% during Q3 2025, and its lowest value of 0.1% during Q4 2022.
  • In the last 5 years, Novartis Ag's Return on Capital Employed had a median value of 0.12% in 2021 and averaged 0.15%.
  • In the last 5 years, Novartis Ag's Return on Capital Employed tumbled by -200bps in 2022 and then surged by 700bps in 2024.
  • Over the past 5 years, Novartis Ag's Return on Capital Employed (Quarter) stood at 0.12% in 2021, then dropped by -17bps to 0.1% in 2022, then increased by 21bps to 0.12% in 2023, then soared by 60bps to 0.2% in 2024, then rose by 10bps to 0.22% in 2025.
  • Its last three reported values are 0.22% in Q4 2025, 0.24% for Q3 2025, and 0.24% during Q2 2025.